Asset Details
Do you wish to reserve the book?
Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine
Do you wish to request the book?
Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine
2018
Overview
Postprandial hyperlipidemia is an important risk factor for cardiovascular diseases in the context of obesity. Inulin is a non-digestible carbohydrate, known for its beneficial properties in metabolic disorders. We investigated the impact of inulin on postprandial hypertriglyceridemia and on lipid metabolism in a mouse model of diet-induced obesity. Mice received a control or a western diet for 4 weeks and were further supplemented or not with inulin for 2 weeks (0.2 g/day per mouse). We performed a lipid tolerance test, measured mRNA expression of genes involved in postprandial lipid metabolism, assessed post-heparin plasma and muscle lipoprotein lipase activity and measured lipid accumulation in the enterocytes and fecal lipid excretion. Inulin supplementation in western diet-fed mice decreases postprandial serum triglycerides concentration, decreases the mRNA expression levels of Cd36 (fatty acid receptor involved in lipid uptake and sensing) and apolipoprotein C3 (Apoc3, inhibitor of lipoprotein lipase) in the jejunum and increases fecal lipid excretion. In conclusion, inulin improves postprandial hypertriglyceridemia by targeting intestinal lipid metabolism. This work confirms the interest of using inulin supplementation in the management of dyslipidemia linked to obesity and cardiometabolic risk.
Publisher
MDPI AG,MDPI
Subject
/ Animals
/ Apolipoprotein C-III - genetics
/ Apolipoprotein C-III - metabolism
/ Hypertriglyceridemia - blood
/ Hypertriglyceridemia - drug therapy
/ Hypertriglyceridemia - genetics
/ Hypolipidemic Agents - pharmacology
/ Intestine, Small - drug effects
/ Intestine, Small - metabolism
/ inulin
/ jejunum
/ Lipid Metabolism - drug effects
/ Lipids
/ Male
/ mice
/ muscles
/ Obesity
/ Rodents
